Adaptive immunity is the primary force driving selection of equine infectious anemia virus envelope SU variants during acute infection

Journal of Virology

Volumn 78, Issue 17, 2004, Pages 9295-9305

  Mealey, Robert H ^a   Leib, Steven R ^a   Pownder, Sarah L ^a   McGuire, Travis C ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENVELOPE PROTEIN;

ADAPTATION; AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN STRUCTURE; ARTICLE; BINDING SITE; COMBINED IMMUNODEFICIENCY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EQUINE INFECTIOUS ANEMIA VIRUS; GENE SEQUENCE; HORSE DISEASE; IMMUNOBIOLOGY; IMMUNOCOMPETENCE; LENTIVIRINAE; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; RECURRENT INFECTION; STATISTICAL SIGNIFICANCE; VIRUS ENVELOPE; VIRUS MORPHOLOGY;

ACUTE DISEASE; AMINO ACID SEQUENCE; ANIMALS; ANTIGENIC VARIATION; EQUINE INFECTIOUS ANEMIA; HORSE DISEASES; HORSES; INFECTIOUS ANEMIA VIRUS, EQUINE; MEMBRANE GLYCOPROTEINS; MOLECULAR SEQUENCE DATA; POINT MUTATION; SELECTION (GENETICS); SEVERE COMBINED IMMUNODEFICIENCY; VARIATION (GENETICS); VIRAL ENVELOPE PROTEINS;

EID: 4143150669     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.78.17.9295-9305.2004     Document Type: Article

References (49)

1. Alexandersen, S., and S. Carpenter. 1991. Characterization of variable regions in the envelope and S3 open reading frame of equine infectious anemia virus. J. Virol. 65:4255-4262.
2. Ball, J. M., K. E. Rushlow, C. J. Issel, and R. C. Montelaro. 1992. Detailed mapping of the antigenicity of the surface unit glycoprotein of equine infectious anemia virus by using synthetic peptide strategies. J. Virol. 66:732-742.
3. Banks, K. L., and T. C. McGuire. 1975. Surface receptors on neutrophils and monocytes from immunodeficient and normal horses. Immunology 28:581-588.
4. Burns, D. P., C. Collignon, and R. C. Desrosiers. 1993. Simian immunodeficiency virus mutants resistant to serum neutralization arise during persistent infection of rhesus monkeys. J. Virol. 67:4104-4113.
5. Burns, D. P., and R. C. Desrosiers. 1991. Selection of genetic variants of simian immunodeficiency virus in persistently infected rhesus monkeys. J. Virol. 65:1843-1854.
6. Carpenter, S., L. H. Evans, M. Sevoian, and B. Chesebro. 1987. Role of the host immune response in selection of equine infectious anemia virus variants. J. Virol. 61:3783-3789.
7. Cheevers, W. P., and T. C. McGuire. 1985. Equine infectious anemia virus: immunopathogenesis and persistence. Rev. Infect. Dis. 7:83-88.
8. Crawford, T. B., K. J. Wardrop, S. J. Tornquist, E. Reilich, K. M. Meyers, and T. C. McGuire. 1996. A primary production deficit in the thrombocytopenia of equine infectious anemia. J. Virol. 70:7842-7850.
9. Evans, D. T., and R. C. Desrosiers. 2001. Immune evasion strategies of the primate lentiviruses. Immunol. Rev. 183:141-158.
10. Evans, D. T., D. H. O'Connor, P. Jing, J. L. Dzuris, J. Sidney, J. da Silva, T. M. Allen, H. Horton, J. E. Venham, R. A. Rudersdorf, T. Vogel, C. D. Pauza, R. E. Bontrop, R. DeMars, A. Sette, A. L. Hughes, and D. I. Watkins. 1999. Virus-specific cytotoxic T-lymphocyte responses select for amino-acid variation in simian immunodeficiency virus Env and Nef. Nat. Med. 5:1270-1276.
11. Ganeshan, S., R. E. Dickover, B. T. Korber, Y. J. Bryson, and S. M. Wolinsky. 1997. Human immunodeficiency virus type 1 genetic evolution in children with different rates of development of disease. J. Virol. 71:663-677.
12. Howe, L., C. Leroux, C. J. Issel, and R. C. Montelaro. 2002. Equine infectious anemia virus envelope evolution in vivo during persistent infection progressively increases resistance to in vitro serum antibody neutralization as a dominant phenotype. J. Virol. 76:10588-10597.
13. Hussain, K. A., C. J. Issel, K. L. Schnorr, P. M. Rwambo, and R. C. Montelaro. 1987. Antigenic analysis of equine infectious anemia virus (EIAV) variants by using monoclonal antibodies: epitopes of glycoprotein gp90 of EIAV stimulate neutralizing antibodies. J. Virol. 61:2956-2961.
14. Johnson, W. E., and R. C. Desrosiers. 2002. Viral persistance: HIV's strategies of immune system evasion. Annu. Rev. Med. 53:499-518.
15. Kim, C. H., and J. W. Casey. 1992. Genomic variation and segregation of equine infectious anemia virus during acute infection. J. Virol. 66:3879-3882.
16. Koch, M., M. Pancera, P. D. Kwong, P. Kolchinsky, C. Grundner, L. Wang, W. A. Hendrickson, J. Sodroski, and R. Wyatt. 2003. Structure-based, targeted deglycosylation of HIV-1 gp120 and effects on neutralization sensitivity and antibody recognition. Virology 313:387-400.
17. Koenig, S., A. J. Conley, Y. A. Brewah, G. M. Jones, S. Leath, L. J. Boots, V. Davey, G. Pantaleo, J. F. Demarest, C. Carter, et al. 1995. Transfer of HIV-1-specific cytotoxic T lymphocytes to an AIDS patient leads to selection for mutant HIV variants and subsequent disease progression. Nat. Med. 1:330-336.
18. Kono, Y. 1988. Antigenic variation of equine infectious anemia virus as detected by virus neutralization. Brief report. Arch. Virol. 98:91-97.
19. Kono, Y., K. Kobayashi, and Y. Fukunaga. 1973. Antigenic drift of equine infectious anemia virus in chronically infected horses. Arch. Gesamte. Virusforsch. 41:1-10.
20. Korber, B. T. 2001. Signature and sequence variation analysis, p. 55-72. In A. G. Rodrigo and G. H. Learn (ed.), Computational and evolutionary analysis of HIV molecular sequences. Kluwer Academic Publishers, Boston, Mass.
21. Leonard, C. K., M. W. Spellman, L. Riddle, R. J. Harris, J. N. Thomas, and T. J. Gregory. 1990. Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells. J. Biol. Chem. 265:10373-10382.
22. Leroux, C., C. J. Issel, and R. C. Montelaro. 1997. Novel and dynamic evolution of equine infectious anemia virus genomic quasispecies associated with sequential disease cycles in an experimentally infected pony. J. Virol. 71:9627-9639.
23. Leutenegger, C. M., J. Higgins, T. B. Matthews, A. F. Tarantal, P. A. Luciw, N. C. Pedersen, and T. W. North. 2001. Real-time TaqMan PCR as a specific and more sensitive alternative to the branched-chain DNA assay for quantitation of simian immunodeficiency virus RNA. AIDS Res. Hum. Retrovir. 17:243-251.
24. Lichtenstein, D. L., C. J. Issel, and R. C. Montelaro. 1996. Genomic quasi-species associated with the initiation of infection and disease in ponies experimentally infected with equine infectious anemia virus. J. Virol. 70:3346-3354.
25. Lin, H. J., T. Tanwandee, and F. B. Hollinger. 1997. Improved methods for quantification of human immunodeficiency virus type 1 RNA and hepatitis C virus RNA in blood using spin column technology and chemiluminescent assays of PCR products. J. Med. Virol. 51:56-63.
26. Magnuson, N. S., L. E. Perryman, C. R. Wyatt, P. H. Mason, and J. E. Talmadge. 1987. Large granular lymphocytes from SCID horses develop potent cytotoxic activity after treatment with human recombinant interleukin 2. J. Immunol. 139:61-67.
27. McGuire, T. C., K. L. Banks, and M. J. Poppie. 1975. Combined immunodeficiency in horses: characterization of the lymphocyte defect. Clin. Immunol. Immunopathol. 3:555-566.
28. McGuire, T. C., S. R. Leib, R. H. Mealey, D. G. Fraser, and D. J. Prieur. 2003. Presentation and binding affinity of equine infectious anemia virus CTL envelope and matrix protein epitopes by an expressed equine classical MHC class I molecule. J. Immunol. 171:1984-1993.
29. Mealey, R. H., D. G. Fraser, J. L. Oaks, G. H. Cantor, and T. C. McGuire. 2001. Immune reconstitution prevents continuous equine infectious anemia virus replication in an Arabian foal with severe combined immunodeficiency: lessons for control of lentiviruses. Clin. Immunol. 101:237-247.
30. Mealey, R. H., B. Zhang, S. R. Leib, M. H. Littke, and T. C. McGuire. 2003. Epitope specificity is critical for high and moderate avidity cytotoxic T lymphocytes associated with control of viral load and clinical disease in horses with equine infectious anemia virus. Virology 313:537-552.
31. Montelaro, R. C., J. M. Ball, and K. E. Rushlow. 1993. Equine retroviruses, p. 257-360. In J. A. Levy (ed.), The Retroviridae. Plenum Press, New York, N.Y.
32. Motulsky, H. 1995. Intuitive biostatistics, p. 217-224. Oxford University Press, New York, N.Y.
33. Motulsky, H. 1995. Intuitive biostatistics, p. 93-105. Oxford University Press, New York, N.Y.
34. Nei, M., and T. Gojobori. 1986. Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions. Mol. Biol. Evol. 3:418-426.
35. Oaks, J. L., T. C. McGuire, C. Ulibarri, and T. B. Crawford. 1998. Equine infectious anemia virus is found in tissue macrophages during subclinical infection. J. Virol. 72:7263-7269.
36. O'Connor, D. H., T. M. Allen, T. U. Vogel, P. Jing, I. P. DeSouza, E. Dodds, E. J. Dunphy, C. Melsaether, B. Mothe, H. Yamamoto, H. Horton, N. Wilson, A. L. Hughes, and D. I. Watkins. 2002. Acute phase cytotoxic T lymphocyte escape is a hallmark of simian immunodeficiency virus infection. Nat. Med. 8:493-499.
37. O'Rourke, K., L. E. Perryman, and T. C. McGuire. 1988. Antiviral, antiglycoprotein and neutralizing antibodies in foals with equine infectious anaemia virus. J. Gen. Virol. 69:667-674.
38. O'Rourke, K. I., L. E. Perryman, and T. C. McGuire. 1989. Cross-neutralizing and subclass characteristics of antibody from horses with equine infectious anemia virus. Vet. Immunol. Immunopathol. 23:41-49.
39. Payne, S., B. Parekh, R. C. Montelaro, and C. J. Issel. 1984. Genomic alterations associated with persistent infections by equine infectious anaemia virus, a retrovirus. J. Gen. Virol. 65:1395-1399.
40. Perryman, L. E., K. I. O'Rourke, and T. C. McGuire. 1988. Immune responses are required to terminate viremia in equine infectious anemia lentivirus infection. J. Virol. 62:3073-3076.
41. Perryman, L. E., and R. L. Torbeck. 1980. Combined immunodeficiency of Arabian horses: confirmation of autosomal recessive mode of inheritance. J. Am. Vet. Med. Assoc. 176:1250-1251.
42. Price, D. A., P. J. Goulder, P. Klenerman, A. K. Sewell, P. J. Easterbrook, M. Troop, C. R. Bangham, and R. E. Phillips. 1997. Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection. Proc. Natl. Acad. Sci. USA 94:1890-1895.
43. Rwambo, P. M., C. J. Issel, W. V. J. Adams, K. A. Hussain, M. Miller, and R. C. Montelaro. 1990. Equine infectious anemia virus (EIAV) humoral responses of recipient ponies and antigenic variation during persistent infection. Arch. Virol. 111:199-212.
44. Salinovich, O., S. L. Payne, R. C. Montelaro, K. A. Hussain, C. J. Issel, and K. L. Schnorr. 1986. Rapid emergence of novel antigenic and genetic variants of equine infectious anemia virus during persistent infection. J. Virol. 57:71-80.
45. Sellon, D. C., F. J. Fuller, and T. C. McGuire. 1994. The immunopathogenesis of equine infectious anemia virus. Virus Res. 32:111-138.
46. Sellon, D. C., S. T. Perry, L. Coggins, and F. J. Fuller. 1992. Wild-type equine infectious anemia virus replicates in vivo predominantly in tissue macrophages, not in peripheral blood monocytes. J. Virol. 66:5906-5913.
47. Shin, E. K., L. E. Perryman, and K. Meek. 1997. A kinase-negative mutation of DNA-PK(CS) in equine SCID results in defective coding and signal joint formation. J. Immunol. 158:3565-3569.
48. Wolinsky, S. M., B. T. Korber, A. U. Neumann, M. Daniels, K. J. Kunstman, A. J. Whetsell, M. R. Furtado, Y. Cao, D. D. Ho, and J. T. Safrit. 1996. Adaptive evolution of human immunodeficiency virus-type 1 during the natural course of infection. Science 272:537-542.
49. Wyatt, R., P. D. Kwong, E. Desjardins, R. W. Sweet, J. Robinson, W. A. Hendrickson, and J. G. Sodroski. 1998. The antigenic structure of the HIV gp120 envelope glycoprotein. Nature 393:705-711.